Ethambutol–sugar hybrids as potential inhibitors of mycobacterial cell-wall biosynthesis
- 1 April 1999
- journal article
- Published by Elsevier in Carbohydrate Research
- Vol. 317 (1-4) , 164-179
- https://doi.org/10.1016/s0008-6215(99)00069-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Tin(IV) chloride mediated glycosylation in arabinofuranose, galactofuranose and rhamnopyranoseTetrahedron Letters, 1998
- Homologated aza analogs of arabinose as antimycobacterial agentsBioorganic & Medicinal Chemistry Letters, 1998
- Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelopeAntimicrobial Agents and Chemotherapy, 1995
- Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drugAntimicrobial Agents and Chemotherapy, 1993
- Problems in the Management of Opportunistic Infections in Patients Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1990
- Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 1989
- Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1986
- Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 1979
- STRUCTURE‐ACTIVITY STUDIES LEADING TO ETHAMBUTOL, A NEW TYPE OF ANTITUBERCULOUS COMPOUND*Annals of the New York Academy of Sciences, 1966
- STEREOSPECIFICITY IN A NEW TYPE OF SYNTHETIC ANTITUBERCULOUS AGENT1,2Journal of the American Chemical Society, 1961